F-Prime Capital

"We are delighted to partner with Proximie and a world class group of investors as the company expands its global footprint and product capabilities. The company is a perfect fit for our ethos of backing best-in-class innovative life sciences businesses that have the capability to positively impact human health and healthcare delivery in paradigm changing ways."

"By taking a rigorous and computer-driven experimental physics approach to analysing proteins, we can go beyond classical drug discovery approaches and observe protein behaviour that algorithms like AlphaFold cannot. This new funding will allow us to further advance our platform and support the investigation of the disordered protein universe towards developing drugs of the future,"

"We are advancing this technology and its application to the hit discovery, hit-to-lead and lead optimization processes of small molecule drug discovery."

"Prior to the pandemic, the hospitality industry had been open to gradually adopting newtechnology. Our business experienced significant growth through 2020 despite the industry headwinds, but 2021 has been a breakthrough year for us as the recovery accelerated the pace of technology adoption. We anticipate unprecedented opportunities and growth as the recovery continues,"